Interaction of age and benefit of treatment intensification in advanced prostate cancer: An aggregate meta-analysis of 14 randomized trials.

Authors

Alicia Morgans

Alicia K. Morgans

Dana-Farber Cancer Institute, Boston, MA

Alicia K. Morgans , Soumyajit Roy , Pedro C. Barata , Jason R Brown , Angela Jia , Nicholas George Zaorsky , Santosh Rao , Prateek Mendiratta , Andrew J. Armstrong , Christopher Sweeney , Gert Attard , Nicholas D. James , Karim Fizazi , Yilun Sun , Daniel Eidelberg Spratt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 118)

DOI

10.1200/JCO.2024.42.4_suppl.118

Abstract #

118

Poster Bd #

E11

Abstract Disclosures

Similar Posters

First Author: Jian Guan

Poster

2024 ASCO Genitourinary Cancers Symposium

Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.

Clinical and patient factors associated with treatment intensification for metastatic castration-sensitive prostate cancer.

First Author: Sreevalsa Appukkuttan